Cita APA

Ocio, E. M., Vilanova, D., Maiso, P., Crusoe, E., Fernández-Lázaro, D., Garayoa, M., . . . San Miguel, J. F. (2010). In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma.

Citación estilo Chicago

Ocio, Enrique M., David Vilanova, Patricia Maiso, Edvan Crusoe, Diego Fernández-Lázaro, Mercedes Garayoa, Laura San-Segundo, Mª Teresa Hernández, y Jesús F. San Miguel. In Vitro and in Vivo Rationale for the Triple Combination of Panobinostat (LBH589) and Dexamethasone With Either Bortezomib or Lenalidomide in Multiple Myeloma. 2010.

Cita MLA

Ocio, Enrique M., et al. In Vitro and in Vivo Rationale for the Triple Combination of Panobinostat (LBH589) and Dexamethasone With Either Bortezomib or Lenalidomide in Multiple Myeloma. 2010.